Key facts
- It has raised $14.5M; the latest was Later Stage VC in Mar 2026.
- Notable investors include Leader Venture Capital, China Growth Capital, Beijing Delian Yuntong Investment Management Company, Fujian Huaxing Venture Capital, Banyan Pacific Capital (Hong Kong) — 11 tracked in total.
- Status: Privately Held (backing).
Investors
11+- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Health Guard Biomed
- ·The full record, as it builds
Funding rounds
No funding rounds for Health Guard Biomed are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Health Guard Biomed
Developer and Manufacturer of medical devices designed to protect patients' vision and improve long-term eye health. The company offers minimally invasive micro-stent implants, precision intraocular pressure monitoring devices, and integrated care tools, enabling healthcare providers and patients to manage glaucoma effectively and safely.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2020
- Website
- healthguard-biomed.com/
- Ownership
- Privately Held (backing)
Health Guard Biomed doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Health Guard Biomed shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Health Guard Biomed in its N-PORT filings yet. We sweep new filings monthly.